Articles From: REPEAT/ Limoneira Announces the Annexation of East Area 1 Into the City of Santa Paula to Repros' Proellex(R) in Breast Cancer Phase 2 Study in Collaboration With Northwestern University


2013/2/13
Limoneira Company (NASDAQ: LMNR) , a leading agribusiness with prime agricultural land and operations, real estate and water rights in California, today announced that on February 12, 2013, East Area 1 was formally annexed into Santa Paula.
Sign-up for REPEAT/ Limoneira Announces the Annexation of East Area 1 Into the City of Santa Paula investment picks
2013/4/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0868970003&sourceType=1 http://www.ccnmatthews.com/logos/20101125-bmonb1125.jpg TORONTO, ONTARIO --
Sign-up for REPEAT/BMO Nesbitt Burns Income Tax Refund Study: More Than One-Third of Canadians Plan on Paying Down Debt investment picks
2013/2/28
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0856480003&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg TORONTO, ONTARIO --
Sign-up for REPEAT/BMO REMINDER: 2012 RRSP Contribution Deadline is Fewer Than 48 Hours Away investment picks
2013/4/27
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0869189003&sourceType=1 http://www.ccnmatthews.com/logos/20051024-bmo_bank_logo.gif http://www.marketwire.com/library/20130425-BMO-426300.jpg In celebration of the Major Mackenzie & Markland branch opening, the BMO ice cream truck will be driving around in select neighbourhoods handing out free ice cream on April 26-27.
Sign-up for REPEAT/MEDIA ADVISORY: BMO Bank of Montreal Celebrates Grand Opening of Major Mackenzie & Markland Branch investment picks
2013/4/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0869189002&sourceType=1 http://www.ccnmatthews.com/logos/20051024-bmo_bank_logo.gif http://www.marketwire.com/library/20130425-BMO-426300.jpg In celebration of the Major Mackenzie & Markland branch opening, the BMO ice cream truck will be driving around in select neighbourhoods handing out free ice cream on April 26-27.
Sign-up for REPEAT/MEDIA ADVISORY: BMO Bank of Montreal Celebrates Grand Opening of Major Mackenzie & Markland Branch investment picks
2013/5/1
The Nebraska Department of Motor Vehicles (DMV) announced the launch of a new free online service for individuals who hold a valid handicap parking permit.
Sign-up for Replacement Handicap Permits Available Online Through Nebraska DMV investment picks
2013/4/19
Please replace the Ortberg photo with the accompanying high-resolution photo.
Sign-up for REPLACING PHOTO Rockwell Collins' Clay Jones to Retire on July 31; Ortberg to Be Named CEO investment picks
2013/2/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0852251001&sourceType=1 http://www.ccnmatthews.com/logos/20110819-RepliC.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for RepliCel Announces Re-Pricing of Warrants investment picks
2013/2/19
VANCOUVER, B.C., Feb.
Sign-up for RepliCel Life Sciences Inc. to Present at the 11th Annual BioPartnering North America Conference investment picks
2013/2/4
VANCOUVER, BC, Feb.
Sign-up for RepliCel to Meet with German Competent Authority on Its RCH-01 Autologous Hair Cell Manufacturing Process investment picks
2013/2/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0850941001&sourceType=1 http://www.ccnmatthews.com/logos/20110819-RepliC.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for RepliCel to Meet with German Competent Authority on Its RCH-01 Autologous Hair Cell Manufacturing Process; Phase II Dose Ranging Trial Planned for 2013 investment picks
2013/2/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0854036001&sourceType=1 http://www.ccnmatthews.com/logos/20110819-RepliC.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for RepliCel to Present at the 11th Annual BioPartnering North America Conference investment picks
2013/5/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0871266001&sourceType=1 http://www.ccnmatthews.com/logos/20110819-RepliC.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for RepliCel's Chief Scientific Officer Updates World Congress for Hair Research on 12-Month Safety Data from Its Phase I Clinical Trial investment picks
2013/5/2
- Total Revenue and Bioprocessing Revenue Grow 28% Over First Quarter 2012 - - Net Income Increases 91% to $2.3 million – - Earnings Conference Call and Webcast Today at 9:00 a.m. EDT - WALTHAM, Mass., May 2, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today reported financial results for the first quarter ended March 31, 2013.
Sign-up for Repligen Reports First Quarter 2013 Financial Results investment picks
2013/3/7
- Bioprocessing Revenue Increases to $42 Million, Total Revenue Reaches $63 Million in 2012 - - Year-over-Year Net Income Increases by $18 Million - WALTHAM, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today reported financial results for its fourth quarter and year ended December 31, 2012.
Sign-up for Repligen Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Financial Guidance for 2013 investment picks
2013/4/23
WALTHAM, Mass., April 23, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today announced that it will report financial results for the first quarter 2013 on Thursday, May 2, 2013.
Sign-up for Repligen to Report First Quarter 2013 Financial Results investment picks
2013/3/1
WALTHAM, Mass., March 1, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) announced today that it will report financial results for the fourth quarter and year ended December 31, 2012 on March 7.
Sign-up for Repligen to Report Fourth Quarter and Full Year 2012 Financial Results investment picks
2013/2/27
A new report detailing the findings from a survey of 40,000 first-year college students from across the U.S. demonstrates to colleges and universities how student financial problems not only impact individual student outcomes but also the institutional mission.
Sign-up for Report Correlates Attitudes and Risky Financial Behaviors among First-Year College Students across U.S., Highlights Institutional Impact investment picks
2013/5/15
NEW YORK , May 15, 2013 /PRNewswire/ -- Standard & Poor's Ratings Services is forecasting that China 's outstanding nonfinancial corporate debt will catch up and surpass the U.S.'s over the next two years, to make the country the largest corporate debt borrower globally.
Sign-up for Report Forecasts $53 Trillion Global Corporate Debt Funding Need Over The Next Five Years investment picks
2013/4/8
ARMONK, N.Y. , April 8, 2013 /PRNewswire/ -- IBM (NYSE: IBM ) today announced that based on Gartner's definition of the application infrastructure and middleware market, IBM has once again been named the overall marketshare leader.
Sign-up for Report: IBM Named Marketshare Leader in Application Infrastructure and Middleware Software for 12 Consecutive Years investment picks
2013/4/18
Disability insurance is crucial to the financial security of working Americans, yet too few employees understand the risks and are covered by this important benefit, says a new report by the Advisory Council on Employee Welfare and Pension Benefit Plans.
Sign-up for Reports highlight need for disability coverage, better education through workplace investment picks
2013/3/27
79-83% in normal testosterone (T) range (FDA requirement 75%) No patient elevated beyond normal range Androxal's impact on sperm concentration meets FDA non-inferiority threshold compared to placebo Potential key points of differentiation from gels THE WOODLANDS, Texas, March 27, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) today reported top-line results for the first pivotal study of Androxal, ZA-301, in the treatment of secondary hypogonadism.
Sign-up for Repros Reports Both Primary Endpoints Successfully Met in First Pivotal Study of Androxal(R) investment picks
2013/2/21
FDA recommends all subjects in study ZA-301 complete as per the original protocol FDA accepts additional enrollment into pivotal study ZA-302 SPA for both pivotal trials remains intact THE WOODLANDS, Texas, Feb.
Sign-up for Repros Reports FDA Recommends Pivotal Study ZA-301 of Androxal(R) to be Completed as Originally Planned investment picks
2013/4/10
Both patents cover the significant co-morbidity associated with low T and Type 2 diabetes US patents 8,372,887 and 8,377,991 will expire in 2028 and 2031, respectively THE WOODLANDS, Texas, April 10, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) announced two patents representing potentially large commercial indications for its drug Androxal have been issued.
Sign-up for Repros Reports Issuance of Two Additional U.S. Androxal(R) Patents investment picks
2013/5/2
THE WOODLANDS, Texas, May 2, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) today announced it has fully enrolled the 180 subject second pivotal study (ZA-302) for Androxal® one month ahead of schedule.
Sign-up for Repros Reports Second Pivotal Androxal(R) Study Fully Enrolled Ahead of Schedule investment picks
2013/2/11
Enrollment in 6 Month Open Label Study Near Completion FDA Meeting Request Submitted Joachim F.
Sign-up for Repros Therapeutics Corporate Update investment picks
2013/5/10
THE WOODLANDS, Texas, May 10, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) today announced financial results for the first quarter ended March 31, 2013.
Sign-up for Repros Therapeutics Inc.(R) Reports First Quarter 2013 Financial Results investment picks
2013/3/18
THE WOODLANDS, Texas, March 18, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) today announced financial results for the quarter and year ended December 31, 2012.
Sign-up for Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2012 Financial Results investment picks
2013/4/29
Company to Webcast Presentation on May 16, 2013 THE WOODLANDS, Texas, April 29, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) today announced that Joseph S.
Sign-up for Repros to Present at the Bank of America Merrill Lynch 2013 Health Care Conference investment picks
2013/4/29
THE WOODLANDS, Texas, April 29, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) announced it is collaborating with Feinberg School of Medicine and the Breast Cancer Program at the Robert H.
Sign-up for Repros' Proellex(R) in Breast Cancer Phase 2 Study in Collaboration With Northwestern University investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: REPEAT/ Limoneira Announces the Annexation of East Area 1 Into the City of Santa Paula to Repros' Proellex(R) in Breast Cancer Phase 2 Study in Collaboration With Northwestern University
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity